Sionna Therapeutics (SION) Profit After Tax (2024 - 2026)
Quarterly results put Profit After Tax at -$26.8 million for Q1 2026, down 62.47% from a year ago — trailing twelve months through Mar 2026 was -$85.6 million (down 29.01% YoY), and the annual figure for FY2025 was -$75.3 million, down 22.01%.
Sionna Therapeutics has reported Profit After Tax over the past 3 years, most recently at -$26.8 million for Q1 2026.
- Profit After Tax reached -$26.8 million in Q1 2026 per SION's latest filing, down from -$20.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$8.6 million in Q2 2024 and bottomed at -$26.8 million in Q1 2026.
- Median Profit After Tax over the past 3 years was -$18.1 million (2025), compared with a mean of -$18.2 million.
- Peak annual rise in Profit After Tax hit 20.29% in 2025, while the deepest fall reached 111.27% in 2025.
- Over 3 years, Profit After Tax stood at -$15.8 million in 2024, then dropped by 28.98% to -$20.4 million in 2025, then tumbled by 31.01% to -$26.8 million in 2026.
- Business Quant data shows Profit After Tax for SION at -$26.8 million in Q1 2026, -$20.4 million in Q4 2025, and -$20.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.63 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | -26.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.78 Mn |
| Dec 31, 2025 | -20.44 Mn |
| Sep 30, 2025 | -20.28 Mn |
| Jun 30, 2025 | -18.07 Mn |
| Mar 31, 2025 | -16.48 Mn |
| Dec 31, 2024 | -15.85 Mn |
| Sep 30, 2024 | -25.44 Mn |
| Jun 30, 2024 | -8.55 Mn |
| Mar 31, 2024 | -11.85 Mn |